Session Details
[O-46]Oral Session 46 Neuroimmunology 6
Sat. May 24, 2025 10:30 AM - 12:00 PM JST
Sat. May 24, 2025 1:30 AM - 3:00 AM UTC
Sat. May 24, 2025 1:30 AM - 3:00 AM UTC
第15会場(リーガロイヤルホテル大阪3F 光琳の間③)
Chair: Motoi Kuwahara(Department od Neurology, Kindai University Faculty of Medicine, Japan)
[O-46-1]Development of severity classification criteria for chronic progressive neuro-Beichet's disease
Shunsei Hirohata1,2,3, Hirotoshi Kikuchi3, Tetsuji Sawada4, Toshihiro Tono7, Izumi Kawachi5,6 (1.Kitasato University School of Medicine, Japan, 2.Nobuhara Clinic, Japan, 3.Teikyo University School of Medicine, Japan, 4.Tokyo Medical University, Japan, 5.Niigata University, Graduate School of Medical and Dental Sciences, Medical Education Center, Japan, 6.Niigata University, Brain Research Institute, Department of Neurology, Japan, 7.Kitasato University School of Medicine, Japan)
[O-46-2]Reactivity to HNK-1 Glycans and Complement Activation in Anti-MAG Antibody-Associated Neuropathy
Yuki Fukami1, Motoi Kuwahara2, Hidenori Ogata3, Satoru Yagi1, Soma Furukawa1, Yoshitaka Nagai2, Noriko Ishobe3, Haruki Koike4, Masahisa Katsuno1,5 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Neurology, Kindai University, Japan, 3.Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Japan, 4.Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan, 5.Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Japan)
[O-46-3]Establishment and Status Report of the CIDP Registry
Hidenori Ogata1, Sonoko Misawa2, Kenichi Kaida3, Haruki Koike4, Shoko Ukita5, Kengo Nagashima5, Noriko Isobe1, Satoshi Kuwabara2, CIDP registry group6 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurology, Graduate School of Medicine, Chiba University, Japan, 3.Department of Neurology, Saitama Medical Center, Saitama Medical University, Japan, 4.Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Saga University, Japan, 5.Clinical and Translational Research Center, Keio University Hospital, Japan, 6.CIDP registry group, Japan)
[O-46-4]ADHERE: Efgartigimod SC in East Asians with Chronic Inflammatory Demyelinating Polyneuropathy
Satoshi Kuwabara1, Jie Lin2, Ting Chang3, Ryo Yamasaki4, Jeffrey Allen5, Zhao Chongbo2, Kenichi Kaida6, Yuki Hatanaka7, Kazuhiro Horiuchi8, Motoi Kuwahara9, Wei Li10, Man Ding11, Yuanqi Zhao12, Yuwei Da13, Song Tan14, Jia-ying Sung15, Peter Ulrichts16, Benjamin Van Hoorick16, Erik Hofman16, Trevor Mole16 (1.Chiba University, Japan, 2.Fudan University, China, 3.The Fourth Military Medical University, China, 4.Kyushu University, Japan, 5.University of Minnesota, USA, 6.Saitama Medical University, Japan, 7.Teikyo University, Japan, 8.Hakodate Municipal Hospital, Japan, 9.Kindai University, Japan, 10.Southern Medical University, China, 11.Wuhan University, China, 12.The Second Clinical College of Guangzhou University of Chinese Medicine, China, 13.Capital Medical University, China, 14.Sichuan Provincial People's Hospital, China, 15.Taipei Medical University, Taiwan, 16.argenx, Belgium)
[O-46-5]Long-term Efficacy of Efgartigimod PH20 SC in CIDP: Interim Results from the ADHERE+ Study
Ryo Yamasaki1, Jeffrel Allen2, Jie Lin3, Mark Stetter4, Jeffrey Guptill5,6, Kelly Gwathmey7, Geoffrey Istas6, Arne De Roeck6, Giuseppe Lauria8, Luis Querol9, Niraja Suresh10, Chafic Karam11, Thomas Skripuletz12, Simon Rinaldi13, Andoni Echaniz - Laguna14, Benjamin Van Hoorick6, Pieter Van Doorn15, Richard Lewis16, Satoshi Kuwabara17 (1.Kyushu University, Japan, 2.University of Minnesota, USA, 3.Fudan University, China, 4.University of Essen, Germany, 5.Duke University, USA, 6.argenx, Belgium, 7.Virginia Commonwealth University, USA, 8.University of Milan, Italy, 9.Universitat Autònoma de Barcelona, Spain, 10.Lakeland Regional Health, USA, 11.University of Pennsylvania, USA, 12.Hannover Medical School, Germany, 13.University of Oxford, UK, 14.Bicêtre Hospital, France, 15.Erasmus University, Netherlands, 16.Cedars-Sinai Medical Center, USA, 17.Chiba University, Neurology, Japan)
[O-46-6]Usefulness of CSF IL-10 in differentiating tumefactive brain lesion from CNS lymphoma
Ryotaro Ikeguchi1, Yuko Shimizu1,2, Kenichi Todo1 (1.Department of Neurology, Tokyo Women's Medical University School of Medicine, Japan, 2.Department of Medical Safety, Tokyo Women's Medical University School of Medicine, Japan)